Based on these findings, it can be concluded that dapagliflozin improves HF by inhibiting ferroptosis, which may be achieved by inhibiting oxidative stress and reducing iron content by regulating Nrf2/HO-1/ GPX4 signaling pathway. The gene discussed is GPX4; the disease is hydrops fetalis.